Patent US4885172A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4885172A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition for targeting, storing and loading of liposomes

Assignee: LIPSOME COMPANY Inc
•
Filing: 1986-12-15
•
Granted: 1989-12-05
•
Expires: 2006-12-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention describes a composition consisting of liposomes covalently or non-covalently coupled to the glycoprotein streptavidin. The streptavidin may additionally be coupled to biotinated proteins such as Immunoglobulin G or monoclonal antibodies. The liposomes of the invention may have a transmembrane potential across their membranes, and may be dehydrated. In addition, the composition may contain ionizable bioactive agents such as antineoplastic agents, and may be used in diagnostic assays.

Inventors

  • 👤 Marcel B. Bally
  • 👤 Helen Loughrey
  • 👤 Pieter R. Cullis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:25
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1271; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/69; A61K47/6905; A61K47/6911; A61K47/6913

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 3 words
A streptavidin-coupled liposome.
Claim 2
Dependent Claim 3 words
A streptavidin-coupled liposome.
Claim 3
Dependent Claim 15 words
The streptavidin-coupled liposome of claim 1 wherein the streptavidin is coupled to the liposome covalently.
Claim 4
Dependent Claim 15 words
The streptavidin-coupled liposome of claim 1 wherein the streptavidin is coupled to the liposome non-covalently.
Claim 5
Dependent Claim 13 words
The streptavidin-coupled liposome of claim 1 wherein the liposome contains a bioactive agent.
Claim 6
Dependent Claim 13 words
The streptavidin-coupled liposome of claim 1 wherein the liposome has a transmembrane potential.
Claim 7
Dependent Claim 13 words
The streptavidin-coupled liposome of claim 5 wherein the liposome contains a bioactive agent.
Claim 8
Dependent Claim 11 words
The streptavidin-coupled liposome of claim 1 wherein the composition is dehydrated.
Claim 9
Dependent Claim 24 words
The streptavidin-coupled liposome of claim 1 wherein the liposome contains a bioactive agent and has a transmembrane potential, and wherein the composition is dehydrated.
Claim 10
Dependent Claim 17 words
A pharmaceutical composition comprising the streptavidin-coupled liposome of claim 1 and a pharmaceutically acceptable carrier or diluent.
Claim 11
Dependent Claim 15 words
The streptavidin-coupled liposome of claim 1 wherein streptavidin is additionally coupled to a biotinated protein.
Claim 12
Dependent Claim 12 words
The streptavidin-coupled liposome of claim 10 wherein the protein is Immunoglobulin G.
Claim 13
Dependent Claim 13 words
The streptavidin-coupled liposome of claim 10 wherein the protein is a monoclonal antibody.
Claim 14
Independent Claim 27 words
A method for preparing a liposome non-covalently coupled to streptavidin comprising the steps of: (a) preparing liposomes comprising biotinylated phosphatidylethanolamine; and (b) incubating the liposomes in streptavidin.
Claim 15
Independent Claim 27 words
A method for preparing a liposome non-covalently coupled to streptavidin comprising the steps of: (a) preparing liposomes comprising biotinylated phosphatidylethanolamine; and (b) incubating the liposomes in streptavidin.
Claim 16
Dependent Claim 12 words
The method of claim 13 wherein the liposomes are large unilamellar vesicles.
Claim 17
Dependent Claim 12 words
The method of claim 13 wherein the liposomes also comprise egg phosphatidylcholine.
Claim 18
Dependent Claim 20 words
The method of claim 15 wherein the biotinylated phosphatidylethanolamine is in an about 0.1%-0.5% mole ratio with the egg phosphatidylcholine.
Claim 19
Dependent Claim 20 words
The method of claim 16 wherein the biotinylated phosphatidylethanolamine is in an about 0.1% mole ratio with the egg phosphatidylcholine.
Claim 20
Dependent Claim 21 words
The method of claim 13 wherein step (b) is performed in about 10 fold molar excess of streptavidin to biotinylated phosphatidylethanolamine.
Claim 21
Dependent Claim 41 words
A method for preparing a protein-coupled streptavidin-biotinylated phosphatidylethanolamine-containing liposome wherein streptavidin is non-covalently coupled to the liposome, comprising the steps of: (a) forming the streptavidin-coupled biotinylated phosphatidylethanolamine liposome of claim 13, and (b) incubating a biotinylated fluorescent-amine-labelled protein with the liposomes.
Claim 22
Dependent Claim 18 words
A composition comprising a protein coupled to streptavidin which is non-covalently coupled to a liposome comprising biotinylated phosphatidylethanolamine.
Claim 23
Dependent Claim 18 words
A composition comprising a protein coupled to streptavidin which is non-covalently coupled to a liposome comprising biotinylated phosphatidylethanolamine.
Claim 24
Dependent Claim 13 words
The composition of claim 20 wherein the liposome is a large unilamellar vesicle.
Claim 25
Dependent Claim 15 words
The composition of claim 20 wherein the protein is an immunoglobulin or a monoclonal antibody.
Claim 26
Dependent Claim 11 words
The composition of claim 22 wherein the immunoglobulin is Immunoglobulin G.
Claim 27
Dependent Claim 10 words
The composition of claim 20 additionally comprising a bioactive agent.
Claim 28
Dependent Claim 16 words
A pharmaceutical composition comprising the composition of claim 20 and a suitable pharmaceutical carrier or diluent.

References Cited (Backward Citations)

US4235871A Cited
US4193983A Cited
US4522803A Cited
US4588578A Cited
US4610868A Cited
US4762720A Cited
US4761288A Cited
WO1986004232A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-04 1993-06-05 1993-12-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-04 1997-06-05 1997-12-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-04 2001-06-05 2001-12-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag